Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

283
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
283
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

579
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
579
REM Sleep Behavior Disorder01:15

REM Sleep Behavior Disorder

213
REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
RBD is significantly associated with...
213
Drug Therapy01:28

Drug Therapy

49
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
49
Neural Regulation01:37

Neural Regulation

39.5K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.5K
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

146
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
146

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Biological characteristics of individuals with REM sleep behavior disorder: A multicenter prospective longitudinal cohort.

Parkinsonism & related disorders·2026
Same author

Early-Onset Parkinson's Disease: Unique Features and Management Approaches.

Current neurology and neuroscience reports·2025
Same author

Segmental and Multifocal Isolated Dystonias: Similarities and Differences.

Movement disorders clinical practice·2025
Same author

Inflammatory changes in early dementia with Lewy bodies.

Frontiers in neurology·2025
Same author

ENLITE PD: A Randomized Clinical Trial of Light Therapy for Impaired Sleep in Parkinson's Disease.

Movement disorders : official journal of the Movement Disorder Society·2025
Same author

Genetic Diversity and Expanded Phenotypes in Dystonia: Insights From Large-Scale Exome Sequencing.

Annals of clinical and translational neurology·2025

相关实验视频

Updated: Jul 13, 2025

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
11:12

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation

Published on: July 16, 2014

22.5K

雷姆睡眠行为障碍:对PD治疗疗法的影响

Jeanne S Feuerstein1,2, Amy Amara3

  • 1Department of Neurology, University of Colorado School of Medicine, Aurora, CO, USA. Jeanne.feuerstein@cuanschutz.edu.

Current neurology and neuroscience reports
|October 13, 2023
PubMed
概括
此摘要是机器生成的。

快速眼动睡眠行为障碍 (RBD) 是帕金森病 (PD) 的一个关键早期症状. 研究正在探索RBD治疗方法及其在开发PD新疗法中的作用.

关键词:
黑色素是什么意思 黑色素是什么意思帕金森病是帕金森氏症的一种疾病.生产性帕金森病的发生.在RBD中,RBD是RBD.雷姆睡眠行为障碍 雷姆睡眠行为障碍综核蛋白病变 (Synucleinopathy) 是一种同核蛋白病变的疾病.

更多相关视频

Applying the RatWalker System for Gait Analysis in a Genetic Rat Model of Parkinson's Disease
04:08

Applying the RatWalker System for Gait Analysis in a Genetic Rat Model of Parkinson's Disease

Published on: January 18, 2021

2.8K
Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease
05:51

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease

Published on: October 14, 2021

3.8K

相关实验视频

Last Updated: Jul 13, 2025

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
11:12

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation

Published on: July 16, 2014

22.5K
Applying the RatWalker System for Gait Analysis in a Genetic Rat Model of Parkinson's Disease
04:08

Applying the RatWalker System for Gait Analysis in a Genetic Rat Model of Parkinson's Disease

Published on: January 18, 2021

2.8K
Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease
05:51

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease

Published on: October 14, 2021

3.8K

科学领域:

  • 神经学 神经学
  • 睡眠医学 睡眠医学
  • 神经退行性疾病 神经退行性疾病

背景情况:

  • 快速眼动睡眠行为障碍 (RBD) 是一种表现为快速眼动睡眠 (REM) 的类型的睡眠障碍,其特征是没有和梦境的快速眼动睡眠.
  • 特别值得注意的是,RBD是同核蛋白病变,特别是帕金森病 (PD) 的前发症特征.

研究的目的:

  • 审查当前对RBD,相关疾病和治疗方法的理解.
  • 探索RBD研究对开发帕金森病治疗方法的影响.

主要方法:

  • 审查当前的基础科学和临床研究RBD.
  • 对RBD病理生理学的动物模型的研究.
  • 对RBD自然史和治疗疗效的临床研究的分析.

主要成果:

  • RBD越来越多地被认为是PD的前性标志物.
  • 目前正在进行的研究重点是RBD病理生理学,动物模型和临床治疗.
  • RBD为开发神经保护性和症状性PD疗法提供了一条新的途径.

结论:

  • RBD是帕金森病的关键早期指标.
  • 对RBD进行进一步的基础科学和临床研究对于推进PD疗法至关重要.
  • 研究RBD为开发PD创新治疗提供了独特的机会.